| The kinase Akt1 controls macrophage response to lipopolysaccharide by regulating microRNAs A Androulidaki, D Iliopoulos, A Arranz, C Doxaki, S Schworer, ... Immunity 31 (2), 220-231, 2009 | 675 | 2009 |
| Akt1 and Akt2 protein kinases differentially contribute to macrophage polarization A Arranz, C Doxaki, E Vergadi, Y Martinez de la Torre, K Vaporidi, ... Proceedings of the National Academy of Sciences 109 (24), 9517-9522, 2012 | 543 | 2012 |
| Therapeutic effects of vasoactive intestinal peptide in the trinitrobenzene sulfonic acid mice model of Crohn's disease C Abad, C Martinez, MG Juarranz, A Arranz, J Leceta, M Delgado, ... Gastroenterology 124 (4), 961-971, 2003 | 284 | 2003 |
| Vasoactive intestinal peptide in the immune system: potential therapeutic role in inflammatory and autoimmune diseases M Delgado, C Abad, C Martinez, M Juarranz, A Arranz, R Gomariz, ... Journal of molecular medicine 80, 16-24, 2002 | 204 | 2002 |
| VIP–PACAP system in immunity: new insights for multitarget therapy RP Gomariz, Y Juarranz, C ABAD, A Arranz, J Leceta, C Martinez Annals of the New York Academy of Sciences 1070 (1), 51-74, 2006 | 158 | 2006 |
| Protective effect of vasoactive intestinal peptide on bone destruction in the collagen-induced arthritis model of rheumatoid arthritis Y Juarranz, C Abad, C Martinez, A Arranz, I Gutierrez-Cañas, F Rosignoli, ... Arthritis research & therapy 7, 1-12, 2005 | 158 | 2005 |
| Anti-inflammatory role in septic shock of pituitary adenylate cyclase-activating polypeptide receptor C Martinez, C Abad, M Delgado, A Arranz, MG Juarranz, ... Proceedings of the National Academy of Sciences 99 (2), 1053-1058, 2002 | 151 | 2002 |
| Modulation of endothelial function by Toll like receptors B Salvador, A Arranz, S Francisco, L Cordoba, C Punzon, MÁ Llamas, ... Pharmacological research 108, 46-56, 2016 | 114 | 2016 |
| VIP down-regulates TLR4 expression and TLR4-mediated chemokine production in human rheumatoid synovial fibroblasts I Gutierrez-Canas, Y Juarranz, B Santiago, A Arranz, C Martinez, ... Rheumatology 45 (5), 527-532, 2006 | 104 | 2006 |
| Time-course expression of Toll-like receptors 2 and 4 in inflammatory bowel disease and homeostatic effect of VIP RP Gomariz, A Arranz, C Abad, M Torroba, C Martinez, F Rosignoli, ... Journal of leukocyte biology 78 (2), 491-502, 2005 | 104 | 2005 |
| Adiponectin promotes endotoxin tolerance in macrophages by inducing IRAK-M expression V Zacharioudaki, A Androulidaki, A Arranz, G Vrentzos, AN Margioris, ... The Journal of Immunology 182 (10), 6444-6451, 2009 | 91 | 2009 |
| cDNA array analysis of cytokines, chemokines, and receptors involved in the development of TNBS-induced colitis: homeostatic role of VIP C Abad, Y Juarranz, C Martinez, A Arranz, F Rosignoli, M García-Gómez, ... Inflammatory bowel diseases 11 (7), 674-684, 2005 | 83 | 2005 |
| Vasoactive intestinal peptide regulates Th17 function in autoimmune inflammation J Leceta, RP Gomariz, C Martinez, M Carrión, A Arranz, Y Juarranz Neuroimmunomodulation 14 (3-4), 134-138, 2007 | 68 | 2007 |
| Advances in optical imaging for pharmacological studies A Arranz, J Ripoll Frontiers in pharmacology 6, 154289, 2015 | 62 | 2015 |
| Peptides targeting Toll-like receptor signalling pathways for novel immune therapeutics RP Gomariz, I Gutierrez-Canas, A Arranz, M Carrion, Y Juarranz, J Leceta, ... Current Pharmaceutical Design 16 (9), 1063-1080, 2010 | 59 | 2010 |
| VIP reverses the expression profiling of TLR4-stimulated signaling pathway in rheumatoid arthritis synovial fibroblasts A Arranz, I Gutiérrez-Cañas, M Carrión, Y Juarranz, JL Pablos, C Martínez, ... Molecular immunology 45 (11), 3065-3073, 2008 | 56 | 2008 |
| Vasoactive intestinal peptide suppresses toll-like receptor 4 expression in macrophages via Akt1 reducing their responsiveness to lipopolysaccharide A Arranz, A Androulidaki, V Zacharioudaki, C Martinez, AN Margioris, ... Molecular immunology 45 (10), 2970-2980, 2008 | 52 | 2008 |
| VIP balances innate and adaptive immune responses induced by specific stimulation of TLR2 and TLR4 A Arranz, Y Juarranz, J Leceta, RP Gomariz, C Martínez Peptides 29 (6), 948-956, 2008 | 51 | 2008 |
| Regulation of TLR expression, a new perspective for the role of VIP in immunity RP Gomariz, A Arranz, Y Juarranz, I Gutierrez-Canas, M Garcia-Gomez, ... Peptides 28 (9), 1825-1832, 2007 | 51 | 2007 |
| Vasoactive intestinal peptide as a healing mediator in Crohn’s disease A Arranz, C Abad, Y Juarranz, J Leceta, C Martinez, RP Gomariz Neuroimmunomodulation 15 (1), 46-53, 2008 | 50 | 2008 |
